NCT00564395View on ClinicalTrials.gov

Detemir: Role in Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

May 31, 2010

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Insulin Detemir mixed with RAI injection

Insulin Detemir mixed with RAI injection is given twice daily as subcutaneous injection

DRUG

Insulin Detemir and RAI injection

Insulin detemir and RAI are given as separate injections, twice daily as subcutaneous injection

Trial Locations (1)

77030

Texas Children's Hospital Endocrine and Diabetes Clinic, Houston

All Listed Sponsors
lead

Montefiore Medical Center

OTHER

NCT00564395 - Detemir: Role in Type 1 Diabetes | Biotech Hunter | Biotech Hunter